Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Triple Negative Breast Neoplasms × Adenosine Diphosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Radiation Injuries 1

Interventions

pembrolizumab 43 Cyclophosphamide 17 Paclitaxel 15 Carboplatin 15 Nivolumab 11 fludarabine 8 Specimen Handling 8 130-nm albumin-bound paclitaxel 8 Taxes 7 Magnetic Resonance Spectroscopy 7 Doxorubicin 7 Biopsy 7 spartalizumab 6 olaparib 6 durvalumab 6 atezolizumab 6 Gemcitabine 6 Cisplatin 6 veliparib 5 liposomal doxorubicin 5 budigalimab 5 Irinotecan 4 Ipilimumab 4 Fulvestrant 4 Everolimus 4 Docetaxel 4 Bevacizumab 4 trametinib 3 eribulin 3 cemiplimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡